Monoclonal antibodies (mAbs) have transformed modern medicine with groundbreaking treatments across a spectrum of diseases, including cancers, autoimmune conditions, and infectious diseases. With a focus on precision and efficiency, Merck® offers advanced solutions for target identification, lead optimization, upstream and downstream processing, formulation, quality control, data analytics, and automation with integrated regulatory expertise, and additional services are designed to address your specific needs on mAb therapeutic to mAb product characterization and biosafety testing. Learn more at https://www.sigmaaldrich.com/HK/en/integrated-offerings/monoclonal-antibodies or talk to ours specialist with your needs.